Clinical trials
Hypercholesterolemia trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2008 | 2 |
| 2013 | 3 |
| 2014 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 5 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 9 |
| 2024 | 5 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 35 |
| Active, not recruiting | 6 |
| Recruiting | 5 |
| Unknown status | 4 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 6 |
| Innovent Biologics (Suzhou) Co. Ltd. | 4 |
| Akeso | 3 |
| AstraZeneca | 3 |
| Jiangsu HengRui Medicine Co., Ltd. | 3 |
| Merck Sharp & Dohme LLC | 3 |
| Sanofi | 3 |
| Amgen | 2 |
| Hasten Biopharmaceutical Co., Ltd. | 2 |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypercholesterolemia | 52 |
| Dyslipidemias | 9 |
| Hyperlipidemias | 7 |
| Hyperlipoproteinemia Type II | 6 |
| Cardiovascular Diseases | 5 |
| Atherosclerosis | 4 |
| Aortic Valve Stenosis | 2 |
| Coronary Artery Disease | 2 |
| Heart Failure | 2 |
| Hypertension | 2 |
Trials
Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.